Back to Articles
Safety8 min readFebruary 22, 2025
Mounjaro and Low Blood Sugar: What You Need to Know
Understanding hypoglycemia risks with tirzepatide. Who's at risk, warning signs, and how to prevent dangerous lows.
By Med Consumer Watch Team
While Mounjaro (tirzepatide) typically doesn't cause low blood sugar on its own, the risk increases significantly when combined with certain other diabetes medications. Here's what you need to know.
When Hypoglycemia Risk Increases
Mounjaro alone rarely causes low blood sugar. Risk increases with:
• Taking insulin alongside tirzepatide
• Using sulfonylureas (glipizide, glimepiride, glyburide)
• Skipping meals while on diabetes medications
• Excessive alcohol consumption
• Intense exercise without adjusting medications
Recognizing Low Blood Sugar
Warning signs include:
- Shakiness or trembling
- Sweating, especially cold sweats
- Fast heartbeat
- Dizziness or lightheadedness
- Hunger
- Irritability or confusion
- Blurred vision
- Weakness or fatigue
Severe hypoglycemia can cause seizures or loss of consciousness. Always have fast-acting glucose available.
Prevention Strategies
To reduce hypoglycemia risk:
• Work with your doctor to adjust insulin doses when starting Mounjaro
• Sulfonylurea doses often need reduction
• Monitor blood sugar more frequently initially
• Eat regular meals—don't skip
• Carry glucose tablets or juice
Many doctors proactively reduce insulin or sulfonylurea doses by 20-50% when starting tirzepatide.
For Non-Diabetics
If you're taking Mounjaro (Zepbound) for weight loss without diabetes:
• Hypoglycemia risk is very low
• Eating less naturally lowers blood sugar slightly
• True hypoglycemia is rare without diabetes medications
• Some tiredness when eating less is normal, not necessarily low blood sugar
The Bottom Line
Mounjaro's hypoglycemia risk comes primarily from interactions with insulin or sulfonylureas, not the medication itself. If you're on combination therapy, work closely with your provider to adjust doses and monitor blood sugar carefully, especially when starting or increasing tirzepatide.
Sources & References
- FDA - Mounjaro Prescribing Information
Medical Disclaimer
This article is for informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare provider before making decisions about your health or medications. Individual experiences may vary.